Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
227M
-
Number of holders
-
92
-
Total 13F shares, excl. options
-
206M
-
Shares change
-
+144M
-
Total reported value, excl. options
-
$171M
-
Value change
-
+$118M
-
Put/Call ratio
-
1.39
-
Number of buys
-
60
-
Number of sells
-
-46
-
Price
-
$0.83
Significant Holders of Gossamer Bio, Inc. - Common Stock (GOSS) as of Q3 2023
130 filings reported holding GOSS - Gossamer Bio, Inc. - Common Stock as of Q3 2023.
Gossamer Bio, Inc. - Common Stock (GOSS) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 206M shares
of 227M outstanding shares and own 90.45% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (15.7M shares), VANGUARD GROUP INC (11.3M shares), EcoR1 Capital, LLC (9.2M shares), Octagon Capital Advisors LP (8.19M shares), ARCH Venture Management, LLC (8.06M shares), MILLENNIUM MANAGEMENT LLC (7.05M shares), Alyeska Investment Group, L.P. (6.8M shares), Palo Alto Investors LP (6.53M shares), Boxer Capital, LLC (6.5M shares), and Artal Group S.A. (6.4M shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.